Life science investor adjusts organization to stay on top of its game

Fresh off of promoting several team members to partners, life science venture capital fund Healthcap's founder Björn Odlander talks about new strategy developments and why pension funds and endowments keep returning to the high-risk sector. He is, however, tight-lipped about past performance.

New biotech Roxiant to tackle age-related diseases

Pharmacosmos heir Andreas Christensen, who recently founded the biotech company Roxiant, will use a protein found in people who live for an exceptionally long time to treat age-related diseases, and its first target is Huntington's disease.

1 - 25 of 80
Trial banner

Latest news

See all jobs